title: Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction.
authors.affiliation: UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain.
authors.forename: Ainhoa
authors.initials: A
authors.lastname: Robles-Mezcua
authors.affiliation: UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain.
authors.forename: Noemí
authors.initials: N
authors.lastname: González-Cruces
authors.affiliation: UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain. Electronic address: amalio_ruiz@hotmail.com.
authors.forename: Amalio
authors.initials: A
authors.lastname: Ruiz-Salas
authors.affiliation: UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain.
authors.forename: Luis
authors.initials: L
authors.lastname: Morcillo-Hidalgo
authors.affiliation: UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain.
authors.forename: Juan
authors.initials: J
authors.lastname: Robledo-Carmona
authors.affiliation: UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain.
authors.forename: Juan José
authors.initials: JJ
authors.lastname: Gómez-Doblas
authors.affiliation: UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain.
authors.forename: Eduardo
authors.initials: E
authors.lastname: de Teresa
authors.affiliation: UGC del Corazón, Instituto de Biomedicina de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Campus Teatinos s/n, Málaga, Spain.
authors.forename: José Manuel
authors.initials: JM
authors.lastname: García-Pinilla
mesh_terms: D000368:Aged; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D005500:Follow-Up Studies; D006333:Heart Failure / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008320:Maltose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D008875:Middle Aged; D011379:Prognosis; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D005290:Ferric Compounds; C522335:ferric carboxymaltose; D008320:Maltose
keywords: Anaemia; Cardiovascular safety; Ferric carboxymaltose; Functional outcome; Intravenous iron; Iron deficiency